Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Syed Hissar

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Plos Pathogens|November 2, 2022
Unique cellular immune signatures of multisystem inflammatory syndrome in childrenAnuradha Rajamanickam, Pavan Kumar Nathella, Aishwarya Venkataraman, et al.
BMC Infectious Diseases|July 25, 2024
Efficacy and tolerability of a 4-month ofloxacin-containing regimen compared to a 6-month regimen in the treatment of patients with superficial lymph node tuberculosis: a randomized trialSyed Hissar, Banurekha Velayutham, Manoharan Tamizhselvan, et al.
Journal of Tropical Pediatrics|August 16, 2024
Xpert MTB/RIF assay in the diagnosis of pulmonary tuberculosis in children in tertiary care setting in South IndiaBanurekha Velayutham, Syed Hissar, Kannan Thiruvengadam, et al.
Trials|April 21, 2018
Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trialChishala Chabala, Anna Turkova, Margaret J Thomason, et al.
The New England Journal of Medicine|March 9, 2022
Shorter Treatment for Nonsevere Tuberculosis in African and Indian ChildrenAnna Turkova, Genevieve H Wills, Eric Wobudeya, et al.
BMJ (Clinical Research Ed.)|April 10, 2026
Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial)Manjula Singh, Sindhu Joshi, Vikram Vohra, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Plos Pathogens|November 2, 2022
Unique cellular immune signatures of multisystem inflammatory syndrome in childrenAnuradha Rajamanickam, Pavan Kumar Nathella, Aishwarya Venkataraman, et al.
BMC Infectious Diseases|July 25, 2024
Efficacy and tolerability of a 4-month ofloxacin-containing regimen compared to a 6-month regimen in the treatment of patients with superficial lymph node tuberculosis: a randomized trialSyed Hissar, Banurekha Velayutham, Manoharan Tamizhselvan, et al.
Journal of Tropical Pediatrics|August 16, 2024
Xpert MTB/RIF assay in the diagnosis of pulmonary tuberculosis in children in tertiary care setting in South IndiaBanurekha Velayutham, Syed Hissar, Kannan Thiruvengadam, et al.
Trials|April 21, 2018
Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trialChishala Chabala, Anna Turkova, Margaret J Thomason, et al.
The New England Journal of Medicine|March 9, 2022
Shorter Treatment for Nonsevere Tuberculosis in African and Indian ChildrenAnna Turkova, Genevieve H Wills, Eric Wobudeya, et al.
BMJ (Clinical Research Ed.)|April 10, 2026
Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial)Manjula Singh, Sindhu Joshi, Vikram Vohra, et al.
Pageof 7